OmicsBox 4.0 adds cloud integration, advanced transcriptomics tools like gene co-expression, and AI-powered summaries ...
The global multiomics market, valued at $3.41 billion in 2025, is forecast to reach $12.82 billion by 2036, growing at a 13.31% CAGR from 2026 to 2036. Growth is driven by precision medicine, ...
Nucleai, a leader in AI-powered tissue intelligence, today announced expanded access to its multimodal spatial analytics platform, through a partnership with the University of Glasgow’s Spatial ...
Background Pancreatic ductal adenocarcinoma (PDAC) is largely refractory to immune checkpoint blockade, owing to its ...
True three-dimensional (3D) spatial biology provides a more physiologically relevant view of tissue biology and cellular interactions than conventional single-cell or two-dimensional (2D) thin-tissue ...
A new study generated one of the most comprehensive spatially resolved transcriptomic maps of cellular communication between ...
The infrastructure moment for AI-driven drug discovery continues to accelerate, with billion-dollar investments flowing into ...
Aqtual, Inc., a precision medicine company developing active chromatin cell-free DNA (cfDNA) diagnostics, today announced the appointments of Ferhan Qureshi as Chief Technology Officer and Bill Arteca ...
Traffic leaves more behind than exhaust. Every mile also grinds away tiny bits of tire rubber, and when one common tire ...
Nomic Bio Inc., today announced they will partner with the Health and Environmental Sciences Institute’s (HESI Global) Omics for Assessing Signatures for Integrated Safety (OASIS) Consortium to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results